164 related articles for article (PubMed ID: 22054074)
1. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
[TBL] [Abstract][Full Text] [Related]
2. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
3. LXR-agonists regulate ApoM expression differentially in liver and intestine.
Calayir E; Becker TM; Kratzer A; Ebner B; Panzenböck U; Stefujl J; Kostner GM
Curr Pharm Biotechnol; 2008 Dec; 9(6):516-21. PubMed ID: 19075690
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells.
Huuskonen J; Vishnu M; Chau P; Fielding PE; Fielding CJ
Biochemistry; 2006 Dec; 45(50):15068-74. PubMed ID: 17154544
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
[TBL] [Abstract][Full Text] [Related]
7. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.
Luo G; Feng Y; Zhang J; Mu Q; Shi Y; Qin L; Zheng L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Int J Med Sci; 2014; 11(10):1015-21. PubMed ID: 25136257
[TBL] [Abstract][Full Text] [Related]
13. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
Murthy S; Born E; Mathur SN; Field FJ
J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
15. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
16. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.
Jiang H; Badralmaa Y; Yang J; Lempicki R; Hazen A; Natarajan V
Lipids Health Dis; 2012 Jul; 11():69. PubMed ID: 22676378
[TBL] [Abstract][Full Text] [Related]
18. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes.
Tsezou A; Iliopoulos D; Malizos KN; Simopoulou T
J Orthop Res; 2010 Aug; 28(8):1033-9. PubMed ID: 20108316
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
[TBL] [Abstract][Full Text] [Related]
20. TO901317, a potent LXR agonist, is an inverse agonist of CAR.
Kanno Y; Tanuma N; Takahashi A; Inouye Y
J Toxicol Sci; 2013; 38(3):309-15. PubMed ID: 23665929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
